Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Post by DJDawgon Jun 13, 2024 2:45pm
229 Views
Post# 36087678

crazy theory

crazy theoryplease take this with a grain of salt.

The new PP closes June 21.
The AGM along with a presentation is on the 19th.

Insiders cannot buy if there is material information known to them but not to the general market.

Recently RDW says that they are hoping to get the final long term data on the 450 day CR patients that they have been chasing in "a few weeks".

What if:
- virtual presentation on the 19th includes some great CR data going up to 24 m and beyond. Any any other updates that are promising.
-insiders and friends can now jump in at this price of 0.22 since all has been disclosed.
- offering closes 21st.
- they fill the whole 10m offering
- no more PP's for a bit.

This is TLT so not expecting this to happen. Just daydreaming.

More likely the presentation will be more of the same.

The PP will raise another 700,000 CAD (not 10M)

Rinse and repeat.



<< Previous
Bullboard Posts
Next >>